Related references
Note: Only part of the references are listed.Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges
Naga Swetha Samji et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Elafibranor Inhibits Chronic Kidney Disease Progression in NASH Mice
Hung-Cheng Tsai et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Elafibranor interrupts adipose dysfunction- mediated gut and liver injury in mice with alcoholic steatohepatitis
Tzu-Hao Li et al.
CLINICAL SCIENCE (2019)
Non-alcoholic fatty liver disease - A global public health perspective
Zobair M. Younossi
JOURNAL OF HEPATOLOGY (2019)
A structured literature review of interventions used in the management of nonalcoholic steatohepatitis (NASH)
Manca Povsic et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2019)
Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice
Bing Xu et al.
JOURNAL OF HEPATOLOGY (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis
Kirstine S. Tolbol et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu et al.
GASTROENTEROLOGY (2016)
Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets
Feliciano Chanana Paquissi
FRONTIERS IN IMMUNOLOGY (2016)
The Immune Landscape in Nonalcoholic Steatohepatitis
Sowmya Narayanan et al.
IMMUNE NETWORK (2016)
Recent insights on the role of cholesterol in non-alcoholic fatty liver disease
Graciela Arguello et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
Michal Pawlak et al.
JOURNAL OF HEPATOLOGY (2015)
Interrelationship between lymphocytes and leptin in fat depots of obese mice revealed by changes in nutritional status
Karine Lolmede et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2015)
Peroxisome proliferator-activated receptor δ: a multifaceted metabolic player
Lazar A. Bojic et al.
CURRENT OPINION IN LIPIDOLOGY (2013)
Hepatoprotective Effects of the Dual Peroxisome Proliferator-Activated Receptor Alpha/Delta Agonist, GFT505, in Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Bart Staels et al.
HEPATOLOGY (2013)
NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications
Geoffrey C. Farrell et al.
GUT AND LIVER (2012)
High-Fat and Fructose Intake Induces Insulin Resistance, Dyslipidemia, and Liver Steatosis and Alters In Vivo Macrophage-to-Feces Reverse Cholesterol Transport in Hamsters
Francois Briand et al.
JOURNAL OF NUTRITION (2012)
Kupffer Cell and Interleukin-12-Dependent Loss of Natural Killer T Cells in Hepatosteatosis
Michael Kremer et al.
HEPATOLOGY (2010)
Accumulation of Natural Killer T Cells in Progressive Nonalcoholic Fatty Liver Disease
Wing-Kin Syn et al.
HEPATOLOGY (2010)
Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
Songwen Zhang et al.
JOURNAL OF HEPATOLOGY (2009)
Effects of fenofibrate on plasma and hepatic transaminase activities and hepatic transaminase gene expression in rats
Akio Kobayashi et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2009)
Senescence of activated stellate cells limits liver fibrosis
Valery Krizhanovsky et al.
CELL (2008)
Alternative M2 activation of Kupffer cells by PPARδ ameliorates obesity-induced insulin resistance
Justin I. Odegaard et al.
CELL METABOLISM (2008)
PPAR alpha, more than PPAR delta, mediates the hepatic and skeletal muscle alterations induced by the PPAR agonist GW0742
Brenda Faiola et al.
TOXICOLOGICAL SCIENCES (2008)
PPARα regulates the hepatotoxic biomarker alanine aminotransferase (ALT1) gene expression in human hepatocytes
Petra Thulin et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
M Watanabe et al.
NATURE (2006)
Cholic acid as key regulator of cholesterol synthesis, intestinal absorption and hepatic storage in mice
C Murphy et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression
L Vergnes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Share Paper
